News & Updates

Obesity does not appear to elevate the risk of death in critically ill patients with COVID-19, results of a study have shown. In addition, patients with BMI <25 kg/m2 have a higher rate of mortality than those with greater BMI levels.

Among people with cardiometabolic diseases (CMD), diets with lower inflammatory potential contribute to larger gray matter and smaller white matter hyperintensity volumes, as well as reduced risk of dementia, according to a study.

Patients with high-risk locally advanced cervical cancer in East Asia get progression-free survival (PFS) boost with pembrolizumab plus concurrent chemoradiotherapy (CCRT), similar to those observed in the overall population of the phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 study.

The presence of jaundice or fluid retention among patients with hepatocellular carcinoma (HCC) is associated with a shorter overall survival (OS), suggests a Singapore study.

A recent study has observed a possible link between cataract surgery and a reduced risk of cognitive impairment and dementia, indicating cataract-related vision impairment as a potentially modifiable risk factor for cognitive decline.

The addition of glofitamab – a CD20xCD3 T-cell engaging bispecific antibody (BsAb) – to gemcitabine and oxaliplatin (GemOx) chemotherapy improves survival in patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) who have received at least one prior line of systemic therapy and are ineligible for autologous stem cell transplant, findings from the phase III STARGLO trial have shown.